Patents Assigned to Thrombotargets Corporation
  • Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
    Patent number: 7772371
    Abstract: The activated coagulation Factor X (FXa) stimulating agents may be used in the treatment of hemorrhages in a subject. Compounds and combinations are described which are particularly useful for the topical treatment of hemorrhaging in healthy subjects or in patients with hemorrhagic diathesis.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: August 10, 2010
    Assignee: Thrombotargets Corporation
    Inventors: Javier Pedreño Egea, Luis Caveda Catasús